Human immunodeficiency virus infection in heterosexual intravenous drug users in San Francisco

248Citations
Citations of this article
35Readers
Mendeley users who have this article in their library.

Abstract

To investigate the risk of infection with the human immunodeficiency virus (HIV) in San Francisco, the prevalence of antibodies to HIV was determined in 281 heterosexual intravenous drug users recruited from community-based settings. Ten per cent of subjects had ELISA and Western blot confirmed seropositivity for antibodies (95 per cent CI 6.8-14.2 per cent). Analysis of behavioral factors revealed an increased risk of seropositivity in addicts who reported regularly sharing needles when injecting, particulary those sharing with two or more persons (odds ratio = 5.43;95 per cent CI 1.08-52.5). Blacks and Latinos also had a greater prevalence of seropositivity than Whites, and this finding persisted after adjustment for needle sharing (adjusted odds ratio = 2.8;95 per cent CI .84-8.59). Seropositivity was not associated with age, sex, duration of drug use, or history of prostitution. These data indicate that a new epidemic of AIDS (aquired immunodeficiency syndrome) in intravenous drug users, similar to that which has occurred among homosexuals in San Francisco, is possible. The relatively low seroprevalence in 1985 provides health officials an important opportunity to intervene and attempt to prevent widespread infection of drug users with HIV.

Cite

CITATION STYLE

APA

Chaisson, R. E., Moss, A. R., Onishi, R., Osmond, D., & Carlson, J. R. (1987). Human immunodeficiency virus infection in heterosexual intravenous drug users in San Francisco. American Journal of Public Health, 77(2), 169–172. https://doi.org/10.2105/AJPH.77.2.169

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free